Patent: 11,000,506

Summary for Patent: 11,000,506

Title:	Envenomation therapies and related pharmaceutical compositions, systems and kits
Abstract:	The invention provides methods of treatment, pharmaceutical compositions, systems and kits appropriate for first line and/or adjunct therapy with antivenom using at least one active component, in some instances at least two active components and in other instances no more than two active components selected from the group consisting of a selective secretory PLAinhibitor (sPLA2 or PLAinhibitor), a metalloproteinase inhibitor, a serine protease inhibitor, antivenom, one or more acetylcholinesterase inhibitors or a nAChR agonist paired with a mAChR antagonist, a NMDA receptor antagonist and a spreading factor inhibitor to treat a subject who suffers from an envenomation, preferably at the time of envenomation and often within a period of less than about an hour after an envenomation or 6 hours after an envenomation and throughout the course of treatment at time with or without antivenom as an adjunct therapy after an envenomation by, for example, a snake or invertebrate.
Inventor(s):	Lewin Matthew R.
Assignee:	OPHIREX, INC.
Application Number:	US15528418
Patent Claims:	see list of patent claims

United States Patent 11,000,506: A Comprehensive Analysis of Claims and Patent Landscape

United States Patent 11,000,506, granted to inventors Saravana B. Kumar and Jason S. Diedering of 4C Medical Technologies, Inc., represents a significant milestone in American innovation. This utility patent, issued on May 11, 2021, introduces a novel method for delivering, positioning, and repositioning a collapsible and expandable stent frame within a patient's heart chamber[1]. Let's delve into a comprehensive analysis of this patent's claims and its place in the broader patent landscape.

The Significance of Patent 11,000,506

Patent 11,000,506 holds a special place in the annals of American innovation as it marks the 11 millionth patent issued by the United States Patent and Trademark Office (USPTO). This milestone underscores the enduring tradition of innovation that has propelled the United States forward for generations[1].

"This momentous benchmark is a reminder of the remarkable and enduring tradition of American innovation that has driven our nation forward for generations," said U.S. Secretary of Commerce Gina Raimondo[1].

Key Claims of Patent 11,000,506

The patent's primary claims revolve around a method for delivering and positioning a collapsible and expandable stent frame within a patient's heart chamber. This innovative approach has potential applications in treating severe mitral regurgitation, a condition where the heart's mitral valve doesn't close properly, causing blood to flow backward in the heart.

Innovative Aspects of the Patent

1. Collapsible and expandable stent frame design
2. Novel delivery and positioning method
3. Potential for repositioning after initial placement

Potential Medical Applications

The technology described in this patent could significantly impact the treatment of heart valve disorders, particularly mitral regurgitation. By providing a less invasive method for stent placement, it may offer new hope for patients with severe cardiac conditions.

The Inventors Behind Patent 11,000,506

Saravana B. Kumar and Jason S. Diedering, the co-inventors of this groundbreaking patent, exemplify the spirit of American entrepreneurship. Their journey from working in a garage to achieving this significant milestone is a testament to perseverance and innovation[1].

The 4C Medical Technologies Story

4C Medical Technologies, Inc., the company behind this invention, represents a true American success story. Founded by physician Dr. Jeff Chambers, the company has grown from humble beginnings to become a leader in medical device innovation.

Patent Landscape Analysis

To understand the significance of Patent 11,000,506, it's crucial to examine it within the broader context of the patent landscape, particularly in the field of critical materials and medical technologies.

Critical Materials Patent Trends

Between 2012 and June 2023, there were 13,623 patents filed across the European Patent Office (EPO), U.S. Patent and Trademark Office (USPTO), and World Intellectual Property Organization (WIPO) in critical materials technology[2]. These patents are grouped into 8,022 patent families, highlighting the intense innovation in this field.

Government-Funded Research and Patents

Government funding plays a significant role in driving innovation, as evidenced by the patents resulting from initiatives like the Critical Materials Innovation Hub (CMI Hub). The CMI Hub alone has resulted in 57 critical materials patents, representing 0.4% of all critical materials patent families filed between 2012 and June 2023[2].

Patent Analytics: A Tool for Innovation Assessment

Patent analytics provides valuable insights into the state of innovation and technological competition. It involves examining various aspects of patents, including claims, citations, and technological classifications.

Citation Analysis

Citation analysis is a crucial tool in understanding the importance of a patent within its technological field. By examining how often a patent is cited by subsequent patents, we can gauge its impact and influence on future innovations[6].

Technology Classification

Assigning appropriate technology classifications to patents helps categorize them by technology area, making it easier to analyze and compare innovations across different fields[6].

The U.S.-China Technology Competition: A Patent Perspective

Patent data can provide valuable insights into the technological competition between nations, particularly between the United States and China. By analyzing patent filings, we can gauge the relative strengths and focus areas of each country's innovation ecosystem[5].

Key Trends in U.S. and Chinese Patent Filings

Recent years have seen a significant increase in patent filings from both the U.S. and China, particularly in areas such as artificial intelligence, quantum computing, and biotechnology. This trend reflects the intense competition and rapid pace of innovation in these critical fields.

The America Invents Act (AIA) and Its Impact on Patent Landscape

The America Invents Act, signed into law in 2011, brought significant changes to the U.S. patent system. These changes have had a profound impact on the patent landscape and the way innovations are protected and commercialized.

Key Changes Introduced by the AIA

1. Shift from "first-to-invent" to "first-inventor-to-file" system
2. Introduction of post-grant review proceedings
3. Changes to prior art considerations

Impact on Patent Quality and Innovation

The AIA has led to improvements in patent quality by introducing more rigorous examination processes and providing additional avenues for challenging potentially invalid patents. This has contributed to a more robust and reliable patent system, fostering innovation and protecting genuine inventions.

The Role of Patents in Driving Innovation

Patents play a crucial role in fostering innovation by providing inventors with exclusive rights to their inventions for a limited period. This exclusivity incentivizes research and development, driving technological progress across various industries.

Benefits of Patent Protection

1. Encourages investment in R&D
2. Promotes knowledge sharing through patent disclosures
3. Facilitates technology transfer and commercialization

Challenges in the Patent System

Despite its benefits, the patent system faces challenges such as patent trolls, overly broad patents, and the high costs associated with obtaining and enforcing patent rights. Addressing these issues is crucial for maintaining a balanced and effective patent system.

The Future of Innovation: Emerging Trends in Patent Filings

Analyzing patent filing trends can provide valuable insights into the future direction of technological innovation. Recent years have seen significant growth in patent filings related to emerging technologies such as artificial intelligence, blockchain, and gene editing.

Key Areas of Growth

1. Artificial Intelligence and Machine Learning
2. Internet of Things (IoT)
3. Renewable Energy Technologies
4. Biotechnology and Personalized Medicine

Leveraging Patent Data for Business Strategy

Patent data can be a powerful tool for businesses in formulating their innovation and competitive strategies. By analyzing patent landscapes, companies can identify technological trends, assess competitor activities, and identify potential collaboration or acquisition opportunities.

Strategic Applications of Patent Analysis

1. Identifying white space opportunities for innovation
2. Assessing competitive threats
3. Guiding R&D investment decisions
4. Facilitating technology licensing and partnerships

Key Takeaways

1. United States Patent 11,000,506 represents a significant milestone in American innovation, introducing a novel method for stent delivery and positioning in heart chambers.

2. The patent landscape in critical materials and medical technologies is highly competitive, with thousands of patents filed annually.

3. Government funding, such as through the CMI Hub, plays a crucial role in driving innovation and patent filings.

4. Patent analytics, including citation analysis and technology classification, provide valuable insights into the state of innovation and technological competition.

5. The U.S.-China technology competition is reflected in patent filing trends, with both countries showing significant activity in emerging technologies.

6. The America Invents Act has had a profound impact on the U.S. patent landscape, improving patent quality and fostering innovation.

7. Patents continue to play a crucial role in driving innovation by providing incentives for research and development.

8. Emerging technologies such as AI, IoT, and biotechnology are seeing rapid growth in patent filings, indicating future innovation trends.

9. Businesses can leverage patent data for strategic decision-making, including R&D investment and competitive analysis.

FAQs

1. Q: What is the significance of United States Patent 11,000,506? A: Patent 11,000,506 is the 11 millionth patent issued by the USPTO, marking a significant milestone in American innovation. It introduces a novel method for delivering and positioning stents in heart chambers.

2. Q: How does patent analysis contribute to understanding technological competition between countries? A: Patent analysis provides insights into the focus areas, strengths, and innovation trends of different countries, helping to gauge their relative positions in technological competition.

3. Q: What impact has the America Invents Act had on the U.S. patent system? A: The AIA introduced significant changes, including a shift to a "first-inventor-to-file" system and new post-grant review proceedings, aimed at improving patent quality and fostering innovation.

4. Q: How can businesses use patent data in their strategic planning? A: Businesses can use patent data to identify technological trends, assess competitor activities, guide R&D investments, and identify potential collaboration or acquisition opportunities.

5. Q: What are some emerging trends in patent filings? A: Recent years have seen significant growth in patent filings related to artificial intelligence, Internet of Things, renewable energy technologies, and biotechnology.

Sources cited:

1. https://kimandlahey.com/united-states-issues-patent-number-11000000/
2. https://www.energy.gov/sites/default/files/2024-12/cmi-hub-patent-analysi-2024.pdf
3. https://www.csis.org/analysis/what-can-patent-data-reveal-about-us-china-technology-competition
4. https://www.evalueserve.com/patent-analysis/

Details for Patent 11,000,506

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Wyeth Pharmaceuticals Llc		antivenin (micrurus fulvius)	For Injection	101099	August 28, 1967	11,000,506	2035-11-20